TMDX
TransMedics Group, Inc.
TransMedics Group, Inc. insider trading
TransMedics Group, Inc. is on this site because an insider bought its stock on the open market in the last 30 days. Every open-market purchase and sale its officers, directors and 10% owners filed in that time is listed below, each linked to the original Form 4.
From SEC filings · last 30 days
Recent TMDX insider transactions
The filing store could not be read just now — this page tries again on its next refresh. The filings themselves are on SEC EDGAR.
SEC Form 4 data, Q3 2024 to Q2 2026
TMDX insider trading by quarter
Between Jul 01, 2024 and Jun 30, 2026, 10 insiders traded TMDX on the open market: 4 purchases worth $3M and 92 sales worth $29.5M, 72 of the sales pre-scheduled under a 10b5-1 plan. In the last four quarters alone: 4 purchases ($3M) and 13 sales ($5.4M), by 8 insiders.
| Quarter | Bought | Sold | Insiders |
|---|---|---|---|
| Q2 2026 | — | −$722.4K1 sale | |
| Q1 2026 | — | −$2.4M7 sales | |
| Q4 2025 | +$1M1 buy | −$1.8M4 sales · 1 on a plan | |
| Q3 2025 | +$2M3 buys | −$520K1 sale · all on a plan | |
| Q2 2025 | — | −$1.5M4 sales · 2 on a plan | |
| Q1 2025 | — | −$270.7K2 sales · 1 on a plan | |
| Q4 2024 | — | −$2.5M18 sales · all on a plan | |
| Q3 2024 | — | −$19.8M55 sales · 49 on a plan |
- Largest purchase
- +$1M of TMDX by Hassanein Waleed H (President & CEO · Director) on Nov 17, 2025.
- Largest sale
- −$4.4M of TMDX by Hassanein Waleed H (President & CEO · Director) on Aug 22, 2024.
Open-market transactions through Jun 30, 2026most recent first
Gunderson Thomas J.
Director
−$722.4K
Jun 15, 2026
9,624 sh · $75.06
Hernandez Gerardo
Chief Financial Officer
−$870.3K
Mar 04, 2026
5,912 sh · $147.21
Weill David
Director
−$524.3K
Mar 04, 2026
3,571 sh · $146.82
Hernandez Gerardo
Chief Financial Officer
−$194.9K
Mar 04, 2026
1,324 sh · $147.21
Lovell Stephanie
Director
−$178.5K
Mar 04, 2026
1,193 sh · $149.62
Corcoran Nicholas
SVP of Supply Chain and Operations
−$412.6K
Mar 02, 2026
2,966 sh · $139.12
Ranganath Anil P.
Senior Vice President, General Counsel and Secretary
−$120.2K
Mar 02, 2026
864 sh · $139.12
Hernandez Gerardo
Chief Financial Officer
−$52.2K
Mar 02, 2026
375 sh · $139.12
Hernandez Gerardo
Chief Financial Officer
−$128.5K
Dec 04, 2025
920 sh · $139.62
Weill David
Director
−$693.2K
Dec 03, 2025
5,000 sh · $138.64
Ranganath Anil P.
Senior Vice President, General Counsel and Secretary
−$435.7K
Nov 25, 2025
3,000 sh · $145.22
Hassanein Waleed H
President & CEO · Director
+$1M
Nov 17, 2025
8,775 sh · $114.00
Basile Edward M10b5-1
Director
−$540.3K
Oct 29, 2025
4,142 sh · $130.45
Hassanein Waleed H
President & CEO · Director
+$768.1K
Aug 07, 2025
6,617 sh · $116.08
Hassanein Waleed H
President & CEO · Director
+$217.1K
Aug 07, 2025
1,858 sh · $116.85
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Jun 15, 2026 | Gunderson Thomas J.Director | 9,624 | $75.06 | −$722.4K |
| Mar 04, 2026 | Hernandez GerardoChief Financial Officer | 5,912 | $147.21 | −$870.3K |
| Mar 04, 2026 | Weill DavidDirector | 3,571 | $146.82 | −$524.3K |
| Mar 04, 2026 | Hernandez GerardoChief Financial Officer | 1,324 | $147.21 | −$194.9K |
| Mar 04, 2026 | Lovell StephanieDirector | 1,193 | $149.62 | −$178.5K |
| Mar 02, 2026 | Corcoran NicholasSVP of Supply Chain and Operations | 2,966 | $139.12 | −$412.6K |
| Mar 02, 2026 | Ranganath Anil P.Senior Vice President, General Counsel and Secretary | 864 | $139.12 | −$120.2K |
| Mar 02, 2026 | Hernandez GerardoChief Financial Officer | 375 | $139.12 | −$52.2K |
| Dec 04, 2025 | Hernandez GerardoChief Financial Officer | 920 | $139.62 | −$128.5K |
| Dec 03, 2025 | Weill DavidDirector | 5,000 | $138.64 | −$693.2K |
| Nov 25, 2025 | Ranganath Anil P.Senior Vice President, General Counsel and Secretary | 3,000 | $145.22 | −$435.7K |
| Nov 17, 2025 | Hassanein Waleed HPresident & CEO · Director | 8,775 | $114.00 | +$1M |
| Oct 29, 2025 | Basile Edward M10b5-1Director | 4,142 | $130.45 | −$540.3K |
| Aug 07, 2025 | Hassanein Waleed HPresident & CEO · Director | 6,617 | $116.08 | +$768.1K |
| Aug 07, 2025 | Hassanein Waleed HPresident & CEO · Director | 1,858 | $116.85 | +$217.1K |
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
Don't check TMDX — let it ping you
Watch every insider filing the minute it clears the SEC
The live dashboard reads every Form 4 as it lands and puts it in plain English — open-market buys, cluster buys where several insiders move at once, and the sales executives chose to make rather than scheduled. Free to open; Pro adds alerts, watchlists and each buyer's track record.
TransMedics Group, Inc. is outside the 777 companies InsiderPulse scans continuously. This page is built from the filings on the live tape and stays up while its insiders are buying. Monitoring, not advice.
Other companies insiders are buying now
Questions
- How much TMDX stock have insiders bought and sold in the last two years?
- Between Jul 01, 2024 and Jun 30, 2026, 10 TransMedics Group, Inc. insiders made 4 open-market purchases worth $3M and 92 sales worth $29.5M. 72 of the sales were pre-scheduled under a Rule 10b5-1 plan. In the four quarters to Jun 30, 2026: 4 purchases ($3M) and 13 sales ($5.4M). The largest purchase was Hassanein Waleed H buying $1M on Nov 17, 2025. The largest sale was Hassanein Waleed H selling $4.4M on Aug 22, 2024.
- Where does TMDX insider trading data come from?
- From the Form 4 filings TransMedics Group, Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.